For citations:
Tokarev A.S., Osmanov I.M., Mazankova L.N., Zakharova I.N., Samitova E.R., Kotenko S.O. Improving the treatment of the novel coronavirus infection (COVID-19) in children at risk for the development of severe disease with the use of virus-neutralizing monoclonal antibodies. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2022;67(3):23-33. (In Russ.) https://doi.org/10.21508/1027-4065-2022-67-3-23-33
Email this article 